What is the efficacy of the quadrivalent human papillomavirus (HPV) vaccines in males?

Updated: Feb 20, 2020
  • Author: Peter A Gearhart, MD; Chief Editor: Pranatharthi Haran Chandrasekar, MBBS, MD  more...
  • Print

A randomized, double-blind, placebo-controlled trial demonstrated that the quadrivalent HPV vaccine prevents infection with HPV types 6, 11, 16, and 18 and prevents the development of related external genital lesions in males aged 16-26 years. [110]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!